Effekt von SATIOSTAT auf die Sättigung, die Darmbakterien und den Zuckerstoffwechsel bei übergewichtigen Personen: eine Machbarkeitsstudie

Dietary Supplement: Control;Dietary Supplement: SATIOSTAT

Inclusion Criteria:

- Obese volunteers (BMI > 30kg/m2)

- Otherwise healthy

- Informed Consent as documented by signature (Appendix Informed Consent Form)

Exclusion Criteria:

- Food allergies, food intolerance

- Evidence of relevant cardiovascular, pulmonary, renal, hepatic, pancreatic,
gastrointestinal, metabolic, endocrinological, neurological, psychiatric or other
diseases at screening

- Chronic or clinically relevant acute infections

- Clinically relevant abnormalities in chemical, haematological or any other laboratory
parameters

- Participation in drug trials within 2 months before start of the study

- Neurological or psychiatric disease or drug or alcohol abuse, which would interfere
with the subjects proper completion of the protocol assignment

- Pregnancy: although no contraindication pregnancy might influence metabolic state.
Women who are pregnant or have the intention to become pregnant during the course of
the study are excluded. In female participants of childbearing age not using safe
contraception (oral, injectable, or implantable contraceptives, or intrauterine
contraceptive devices) a urine pregnancy test is carried out upon screening.

- Antibiotic therapy within the last 3 months before inclusion

- Substance abuse, alcohol abuse

- Inability to follow procedures due to psychological disorders, dementia or
insufficient

- Knowledge of project language (German).

- Participation in another study with investigational drug within the 30 days preceding
and during the present study.